Evidence map›Paper›PMID 39421707›Full record

ArticleContemporary oncology (Poznan, Poland)2024

Characteristics and outcomes of patients with lymphoma who developed therapy-related acute myeloid leukemia or myelodysplastic syndrome - a retrospective analysis of the Polish Adult Leukemia Group.

Aleksandra Gołos, Damian Mikulski, Monika Grobelska-Kowalik, Krzysztof Mądry, Karol Lis, Marta Sobas, Agnieszka Ożańska, Magdalena Czemerska, Dorota Hawrylecka, Agnieszka Stelmach-Gołdyś and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Contemporary oncology (Poznan, Poland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Aleksandra GołosHematology Department, Medical University of Łódź, Łódź, Poland.
Damian MikulskiDepartment Of Biostatistics And Translational Medicine, Medical University of Łódź, Łódź, Poland.
Monika Grobelska-KowalikHematooncology Department, Provincial Multi-Specialized Oncology and Trauma Center, Łódź, Poland.
Krzysztof MądryDepartment of Hematology, Transplantation and Internal Medicine, Medical University of Warsaw, Warsaw, Poland.
Karol LisDepartment of Hematology, Transplantation and Internal Medicine, Medical University of Warsaw, Warsaw, Poland.
Marta SobasDepartment and Clinic of Haematology, Blood Neoplasms, and Bone Marrow Transplantation, Wrocław Medical University, Wrocław, Poland.
Agnieszka OżańskaDepartment and Clinic of Haematology, Blood Neoplasms, and Bone Marrow Transplantation, Wrocław Medical University, Wrocław, Poland.
Magdalena CzemerskaHematology Department, Medical University of Łódź, Łódź, Poland.
Dorota HawryleckaDepartment of Hematology, Hospital Brzozów, Brzozów, Poland.
Agnieszka Stelmach-GołdyśDepartment of Hematology, Holy Cross Cancer Centre, Kielce, Poland.
Karolina ChromikDepartment of Hematology and Bone Marrow Transplantation, Medical University of Silesia, School of Medicine in Katowice, Katowice, Poland.
Bartosz PułaDepartment of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.
Małgorzata Sobczyk-KruszelnickaDepartment of Bone Marrow Transplantation and Oncohematology, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Joanna Góra-TyborHematology Department, Medical University of Łódź, Łódź, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Enhancing lymphoma outcomes increases the risk of therapy-related neoplasms such as acute myeloid leukemia (t-AML) and myelodysplastic syndrome (t-MDS). Material and methods: Our study, conducted at seven Polish hematology centers between 2011 and 2018, explores clinical features, outcomes, and prognostic factors of t-AML and t-MDS arising after initial lymphoid neoplasms. Results: The analysis included 57 patients of median age 65 with t-MDS ( Conclusions: Anemia and thrombocytopenia may indicate more severe impairment of bone marrow function, resulting in further inferior treatment outcomes.

Indexed as

lymphomatherapy- related acute myeloid leukemiatherapy-related myelodysplastic syndrometherapy-related myeloid neoplasm

Identifiers

PMID39421707
PMCPMC11480911

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.